Sat12142019

Last updateTue, 10 Dec 2019 11am

Back You are here: Inicio Biology & biomedicine

Synthetic peptides for fighting metastasis related to the interleukin receptor IL13Rα2

The CSIC has developed a peptide capable of inhibiting the signaling of interleukin 13 mediated by the IL13Rα2 alpha receptor, one of the pathways that contribute metastasis according to recent studies. The synthetic peptide, alone or encapsulated, could be used for the control of metastasis of colon cancer and other tumours such as glioblastoma, as well as in pathologies such as asthma, atopic dermatitis or fibrosis, related to the same receptor, although more assays are required to confirm its efectivity in humans.

Read more ...

New targets and orphan drugs for rare diseases

Scientists at the Centro de Investigaciones Biológicas (CIB) of the CSIC work to find out the genetic diagnosis of rare diseases related to vascular disorders and tumors, as well as to find new therapies. Their research has focused mainly on the HHT disease and the Von Hippel-Lindau syndrome, and they have found out three orphan molecules for treating the HHT disease and one for the treatment of VHL.

Read more ...

A fast test for the analysis of oral tolerance to triglycerides

The Instituto de la Grasa of the CSIC and the University of Sevilla have developed a method for analysing oral tolerance to lipids (triglycerides) from the diet, in humans, in only 4 hours. The method is easier and faster than the current ones.

Read more ...

Artificial intelligence for the diagnosis of rare diseases related to collagen VI

Researchers at the Institute of Robotics and Industrial Informatics -a joint center of the CSIC and the Polytechnic University of Catalonia-, and at the Sant Joan de Déu Hospital in Barcelona, have developed a system for helping in the diagnoses of rare diseases related to deficiencies in the structure of collagen VI.

Read more ...

TEC-SALUT Community: RIS3CAT projects for health innovation

RIS3 communities are groups between research institutions and companies, created at the request of the European Union to define and promote scientific projects in strategic sectors in the different European regions. In Catalonia, TEC-SALUT is one of these RIS3CAT communities. It encompasses several projects and has the participation of different CSIC centers. The goal is to create a collaborative space that responds to the challenges of the health system and health technologies.

Read more ...